Document:

Exhibit 4.3

 

 

DUKE ENERGY CAROLINAS, LLC

 

TO

 

THE BANK OF NEW YORK MELLON TRUST COMPANY,
N.A.,

Trustee

 

ONE-HUNDRED AND FOURTH SUPPLEMENTAL INDENTURE

 

Dated as of January 8, 2020

 

 

 

ADDITIONAL ISSUANCE OF

 

$400,000,000 FIRST AND REFUNDING MORTGAGE
BONDS, 3.20% SERIES DUE 2049

 

 

 

SUPPLEMENTAL TO

FIRST AND REFUNDING MORTGAGE

DATED AS OF December 1, 1927

 

 

 

Drawn By and Return To:

Hunton Andrews Kurth LLP

200 Park Avenue

New York, New York 10166

Attention: Brendan P. Harney

 

     

     

    

 

SUPPLEMENTAL INDENTURE,
bearing date as of the 8th day of January, 2020, made and entered into by and between Duke Energy Carolinas, LLC, a
limited liability company duly organized and existing under the laws of the State of North Carolina, hereinafter called the “Company”,
party of the first part, and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company,
N.A.), a national banking association, having a corporate trust office at 10161 Centurion Parkway N., Jacksonville, Florida 32256,
hereinafter called the “Trustee”, as Trustee, party of the second part. The Trustee is the successor to JPMorgan Chase
Bank, N.A. (formerly known as The Chase Manhattan Bank, formerly known as Chemical Bank (successor to Morgan Guaranty Trust Company
of New York)), as Trustee.

 

WHEREAS the Company’s
predecessor is Duke Energy Corporation (formerly known as Duke Power Company), a corporation organized under the laws of the State
of North Carolina, which converted its form of organization on April 3, 2006 from a North Carolina corporation to a North Carolina
limited liability company named “Duke Power Company LLC,” which changed its name to Duke Energy Carolinas, LLC on October
1, 2006; and

 

WHEREAS Duke Power
Company, a New Jersey corporation, hereinafter called the “New Jersey Company”, duly executed and delivered its First
and Refunding Mortgage, dated as of December 1, 1927, to Guaranty Trust Company of New York, as Trustee, to secure its First and
Refunding Mortgage Gold Bonds, to be issued from time to time in series as provided in said Mortgage, and has from time to time
duly executed and delivered supplemental indentures, including supplemental indentures dated as of September 1, 1947 and February
1, 1949, to Guaranty Trust Company of New York (the corporate name of which has been changed to Morgan Guaranty Trust Company of
New York), as Trustee, and a supplemental indenture dated as of February 1, 1960 to Morgan Guaranty Trust Company of New York,
as Trustee, supplementing and modifying said Mortgage (said Mortgage, as so supplemented and modified by the supplemental indentures
dated as of September 1, 1947, February 1, 1949 and February 1, 1960, being hereinafter referred to as the “original
indenture”); and

 

    1

     

    

 

WHEREAS bonds of
a series known as the “First and Refunding Mortgage Bonds, 2.65% Series Due 1977” (herein called “bonds of
the 2.65% Series”), bonds of a series known as the “First and Refunding Mortgage Bonds, 2 7/8% Series Due
1979” (herein called “bonds of the 1979 Series”), bonds of a series known as the “First and Refunding
Mortgage Bonds, 6 3/8% Series Due 1998” (herein called “bonds of the 1998 Series”), bonds of a series known
as the “First and Refunding Mortgage Bonds, Pollution Control Facilities Revenue Refunding Series Due 2014”
(herein called “bonds of the 1990 Pollution Control Series”), bonds of a series known as the “First and
Refunding Mortgage Bonds, City of Greensboro Series Due 2027” (herein called “bonds of the 2027 City of
Greensboro Series”), bonds of a series known as the “First and Refunding Mortgage Bonds, Medium-Term Notes
Series” (herein called “bonds of the Medium-Term Notes Series”), bonds of a series known as the
“First and Refunding Mortgage Bonds, 6 5/8% Series B Due 2003” (herein called “bonds of the 2003 Series
B”), bonds of a series known as the “First and Refunding Mortgage Bonds, 6 3/8% Series Due 2008” (herein
called “bonds of the 2008 Series”), bonds of a series known as the “First and Refunding Mortgage Bonds, 5
7/8% Series C Due 2003” (herein called “bonds of the 2003 Series C”), bonds of a series known as the
“First and Refunding Mortgage Bonds, Pollution Control Facilities Revenue Refunding Series Due 2014” (herein
called “bonds of the 1993 Pollution Control Series”), bonds of a series known as the “First and Refunding
Mortgage Bonds, 6 1/4% Series B 2004” (herein called “bonds of the 2004 Series B”), bonds of a series known
as the “First and Refunding Mortgage Bonds, 7% Series Due 2033” (herein called “bonds of the
2033 Series”), bonds of a series known as the “First and Refunding Mortgage Bonds, 6 7/8% Series B Due
2023” (herein called “bonds of the 2023 Series B”), bonds of a series known as the “First and
Refunding Mortgage Bonds, 6 3/4% Series Due 2025” (herein called “bonds of the 2025 Series”), bonds of a
series known as the “First and Refunding Mortgage Bonds, 7 7/8% Series Due 2024” (herein called “bonds of
the 2024 Series”), bonds of a series known as the “First and Refunding Mortgage Bonds, 7 1/2% Series B Due
2025” (herein called “bonds of the 2025 Series B”), bonds of a series known as the “First and
Refunding Mortgage Bonds, 7 1/2% Series Due 1999” (herein called “bonds of the 1999 Series”), bonds of a
series known as the “First and Refunding Mortgage Bonds, 7% Series Due 2000” (herein called “bonds of the
2000 Series”), bonds of a series known as the “First and Refunding Mortgage Bonds, 7% Series B Due 2000”
(herein called “bonds of the 2000 Series B”), bonds of a series known as the “First and Refunding Mortgage
Bonds, 6.625% Series Due 2003” (herein called “bonds of the 2003 Series”), bonds of a series known as the
“First and Refunding Mortgage Bonds, 9 5/8% Series Due 2020” (herein called “bonds of the 9 5/8% Series due
2020”), bonds of a series known as the “First and Refunding Mortgage Bonds, 8 3/4% Series Due 2021” (herein
called “bonds of the 2021 Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 7%
Series Due 2005” (herein called “bonds of the 2005 Series”), bonds of a series known as “First and
Refunding Mortgage Bonds, 3.75% Series A Due 2008” (herein called “bonds of the 3.75% Series A”), bonds of
series known as “First and Refunding Mortgage Bonds, 3.75% Series B Due 2008” (herein called “bonds of the
3.75% Series B,” and together with the bonds of the 3.75% Series A, the “bonds of the 3.75% Series”), bonds
of a series known as “First and Refunding Mortgage Bonds, 7 3/8% Series Due 2023” (herein called “bonds of
the 7 3/8% Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 4 1/2% Series Due
2010” (herein called “bonds of the 4 1/2% Series”), bonds of a series known as “First and Refunding
Mortgage Bonds, 5.30% Series Due 2015” (herein called “bonds of the 5.30% Series”), bonds of a series known
as “First and Refunding Mortgage Bonds, 5.25% Series Due 2018” (herein called “bonds of the 5.25%
Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 6.00% Series Due 2038” (herein
called “bonds of the 6.00% Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 2007A
Pledge Series Due 2040” (herein called “bonds of the 2007A Pledge Series”), bonds of a series known as
“First and Refunding Mortgage Bonds, 2007B Pledge Series Due 2040” (herein called “bonds of the 2007B
Pledge Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 5.10% Series B Due 2018”
(herein called “bonds of the 5.10% Series”), bonds of a series known as “First and Refunding Mortgage
Bonds, 6.05% Series B Due 2038” (herein called “bonds of the 6.05% Series”), bonds of a series known as
“First and Refunding Mortgage Bonds, 7.00% Series C Due 2018 (herein called “bonds of the 2018 Series C”),
bonds of a series known as “First and Refunding Mortgage Bonds, 5.30% Series Due 2040” (herein called
“bonds of the 2040 Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 4.30% Series
due 2020”(herein called “bonds of the 2020 Series”), bonds of a series known as “First and Refunding
Mortgage Bonds, Solid Waste Disposal Revenue Bonds Series 2010A Due 2031” (herein called “bonds of the 2010A
Solid Waste Disposal Series”), bonds of a series known as “First and Refunding Mortgage Bonds, Solid Waste
Disposal Revenue Bonds Series 2010B Due 2031” (herein called “bonds of the 2010B Solid Waste Disposal
Series”), bonds of a series known as “First and Refunding Mortgage Bonds, Solid Waste Disposal Revenue Bonds
Series 2010C Due 2040” (herein called “bonds of the 2010C Solid Waste Disposal Series”), bonds of a series
known as “First and Refunding Mortgage Bonds, Solid Waste Disposal Revenue Bonds Series 2010D Due 2040 (herein called
“bonds of the 2010D Solid Waste Disposal Series”), bonds of a series known as “First and Refunding Mortgage
Bonds, 3.90% Series due 2021” (herein called “bonds of the 3.90% Series”), bonds of a series known as
“First and Refunding Mortgage Bonds, 1.75% Series due 2016” (herein called “bonds of the 1.75%
Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 4.25% Series due 2041” (herein
called “bonds of the 4.25% Series”), bonds of a series known as “First and Refunding Mortgage Bonds, 4.00%
Series due 2042” (herein called “bonds of the 4.00% Series”), bonds of a series known as “First and
Refunding Mortgage Bonds, 3.75% Series due 2045” (herein called “bonds of the 3.75% Series due 2045”),
bonds of a series known as “First and Refunding Mortgage Bonds, 2.500% Series due 2023” (herein called
“bonds of the 2.500% Series due 2023”), bonds of a series known as “First and Refunding Mortgage Bonds,
3.875% Series due 2046” (herein called “bonds of the 3.875% Series due 2046”), bonds of a series known as
“First and Refunding Mortgage Bonds, 2.95% Series due 2026” (herein called “bonds of the 2.95% Series due
2026”), bonds of a series known as “First and Refunding Mortgage Bonds, 3.70% Series due 2047” (herein
called “bonds of the 3.70% Series due 2047”), bonds of a series known as “First and Refunding Mortgage
Bonds, 3.05% Series due 2023” (herein called “bonds of the 3.05% Series due 2023”), bonds of a series known
as “First and Refunding Mortgage Bonds, 3.95% Series due 2048 (herein called “bonds of the 3.95% Series due
2048”), bonds of a series known as “First and Refunding Mortgage Bonds, 3.35% Series due 2022” (herein
called “bonds of the 3.35% Series due 2022”), bonds of a series known as “First and Refunding Mortgage
Bonds, 3.95% Series due 2028” (herein called “bonds of the 3.95% Series due 2028”), bonds of a series known
as “First and Refunding Mortgage Bonds, 2.45% Series due 2029” (herein called “bonds of the 2.45% Series
due 2029”), bonds of a series known as “First and Refunding Mortgage Bonds, 3.20% Series due 2049” (herein
called “bonds of the 3.20% Series due 2049”) and such other bonds that have heretofore been issued and (except
for bonds of the 2.65% Series, bonds of the 1979 Series, bonds of the 1998 Series, bonds of the 1990 Pollution Control
Series, bonds of the Medium Term Notes Series, bonds of the 2003 Series B, bonds of the 2008 Series, bonds of the 2003 Series
C, bonds of the 1993 Pollution Control Series, bonds of the 2004 Series B, bonds of the 2033 Series, bonds of the 2023 Series
B, bonds of the 2025 Series, bonds of the 2024 Series, bonds of the 2025 Series B, bonds of the 1999 Series, bonds of the
2000 Series, bonds of the 2000 Series B, bonds of the 2003 Series, bonds of the 9 5/8% Series due 2020, bonds of the 2021
Series, bonds of the 2005 Series, bonds of the 3.75% Series, bonds of the 7 3/8% Series, bonds of the 2007A Pledge Series,
bonds of the 2007B Pledge Series, bonds of the 4 1/2% Series, bonds of the 5.30% Series, bonds of a series known as
“First and Refunding Mortgage Bonds, Pollution Control Facilities Revenue Refunding Series Due 2017,” bonds of
the 1.75% Series, bonds of the 5.25% Series, bonds of the 5.10% Series, bonds of the 2018 Series C and other such bonds which
have been redeemed or retired in their entirety ) are the only bonds now outstanding under the original indenture as
heretofore supplemented; and

 

    2

     

    

 

WHEREAS the Company
has duly executed and delivered a supplemental indenture, dated as of June 15, 1964, to Morgan Guaranty Trust Company of New York,
as Trustee, for the purpose of evidencing the succession by merger of the Company to the New Jersey Company and the assumption
by the Company of the covenants and conditions of the New Jersey Company in the original indenture and to enable the Company to
have and exercise the powers and rights of the New Jersey Company under the original indenture in accordance with the terms thereof
and whereby the Company assumed and agreed to pay duly and punctually the principal of and interest on the bonds issued under the
original indenture in accordance with the provisions of said bonds and the coupons thereto appertaining and the original indenture,
and agreed to perform and fulfill all the terms, covenants and conditions of the original indenture binding upon the New Jersey
Company, and

 

WHEREAS Morgan Guaranty
Trust Company of New York resigned as Trustee under the original indenture as heretofore supplemented and Chemical Bank was appointed
successor Trustee, said resignation and appointment having taken effect on August 30, 1994 pursuant to an Instrument of Resignation,
Appointment and Acceptance dated as of August 30, 1994 among the Company, Morgan Guaranty Trust Company of New York, as Trustee,
and Chemical Bank (now known as JPMorgan Chase Bank, N.A.), as successor Trustee; and

 

WHEREAS JPMorgan Chase
Bank, N.A. resigned as Trustee and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust
Company, N.A.) was appointed successor Trustee, said resignation and appointment having taken effect on September 24, 2007 pursuant
to an Instrument of Resignation, Appointment and Acceptance dated as of September 24, 2007 among the Company, JPMorgan Chase Bank,
N.A., as Trustee, and The Bank of New York Mellon Trust Company, N.A., as successor Trustee; and

 

WHEREAS the Company
desires to issue additional bonds of the 3.20% Series due 2049 under the original indenture, as heretofore supplemented and as
to be supplemented by this supplemental indenture, initially in an aggregate principal amount of $400,000,000 (hereinafter referred
to as the “Additional Bonds of the 3.20% Series”); and

 

    3

     

    

 

WHEREAS the terms and provisions of the
Additional Bonds of the 3.20% Series, and the form thereof, were set forth in the One-Hundred and Second Supplemental Indenture,
dated as of August 14, 2019, between the Company and the Trustee (hereinafter sometimes referred to as the “One-Hundred and
Second Supplemental Indenture”), which One-Hundred and Second Supplemental Indenture also provided for the issuance of $350,000,000
aggregate principal amount of the bonds of the 3.20% Series due 2049; and

 

WHEREAS Section 2.5
of the One-Hundred and Second Supplemental Indenture provides that the Company may, without the consent of the holders of the bonds
of the 3.20% Series due 2049, reopen the bonds of the 3.20% Series due 2049 and issue an unlimited amount of additional bonds having
the same ranking, interest rate, maturity and other terms as the previously issued bonds of the 3.20% Series due 2049, provided,
that, such Additional Bonds of the 3.20% Series are fungible with the previously issued bonds of the 3.20% Series due 2049 for
United States federal income tax purposes; and

 

WHEREAS for the purposes
hereinabove recited, and pursuant to due limited liability company action, the Company has duly determined to execute and deliver
to the Trustee a supplemental indenture in the form hereof supplementing the original indenture (the original indenture, as previously
supplemented by supplemental indentures and as hereby supplemented, being sometimes hereinafter referred to as the “Indenture”);
and

 

WHEREAS all conditions
and requirements necessary to make this supplemental indenture a valid, legal and binding instrument in accordance with its terms
have been done and performed, and the execution and delivery hereof have been in all respects duly authorized:

 

NOW, THEREFORE, THIS
INDENTURE WITNESSETH:

 

That in consideration
of the premises and of the sum of one dollar duly paid by the Company to the Trustee at or before the execution and delivery of
these presents, the receipt whereof is hereby acknowledged, the Company hereby covenants and agrees with the Trustee and its successors
in the trust under the Indenture as follows:

 

PART
One. 

 

SECTION 1.       
Issuance of Additional Bonds of the 3.20%
Series

 

Section 1.1.        
There is hereby authorized and established Additional Bonds of the 3.20% Series designated “First and Refunding
Mortgage Bonds, 3.20% Series due 2049,” which shall be consolidated with, and form a single series with, the bonds of the
3.20% Series due 2049. The Additional Bonds of the 3.20% Series, which are authenticated and delivered hereunder, shall be initially
limited to an aggregate principal amount of $400,000,000, and immediately after the issuance of the Additional Bonds of the 3.20%
Series, the aggregate principal amount of the bonds of the 3.20% Series due 2049, together with the Additional Bonds of the 3.20%
Series, shall be $400,000,000. The terms and conditions of the Additional Bonds of the 3.20% Series are the same as those of the
bonds of the 3.20% Series due 2049 as specified in the One-Hundred and Second Supplemental Indenture.

 

    4

     

    

 

PART
Two.

 

MISCELLANEOUS.

 

SECTION 1.       
 

 

(a)       For
the purposes of §2.10 of the Indenture and for the purposes of any modification of the provisions of the Replacement Fund
referred to in Part Two of the One-Hundred and Second Supplemental Indenture, the covenants and provisions on the part of the Company
which are set forth or incorporated in Part Two of the One-Hundred and Second Supplemental Indenture shall be for the benefit only
of the holders of the bonds of the 3.20% Series due 2049, including the Additional Bonds of the 3.20% Series. Such covenants and
provisions shall remain in force and be applicable only so long as any bonds of the 3.20% Series due 2049, including the Additional
Bonds of the 3.20% Series, shall be outstanding, and, subject to the provisions of paragraph (2) of subdivision (c) of §10.01
of the Indenture, any such covenants and provisions may be modified with respect to the bonds of the 3.20% Series due 2049, including
the Additional Bonds of the 3.20% Series, with the consent, in writing or by vote at a bondholders’ meeting of the holders
of sixty-six and two-thirds per cent (66 2/3%) of the principal amount of the bonds of the 3.20% Series due 2049 at the time outstanding,
including the Additional Bonds of the 3.20% Series, and without the consent of the holders of any other bonds then outstanding
under the Indenture; provided that no such consent shall be effective to waive any past default under such covenants and
provisions, and its consequences, unless the consent of the holders of at least a majority in principal amount of all bonds then
outstanding under the Indenture is obtained. Such covenants shall be deemed to be additional covenants and none of them shall affect
or derogate from, or relieve the Company from, its obligation to comply with any of the other covenants, conditions, requirements
or provisions of the Indenture or any other supplemental indenture.

 

(b)      For the purposes
of §2.10 of the Indenture and for the purposes of any modification of the provisions of Part Three of the One-Hundred and
Second Supplemental Indenture, the covenants and provisions on the part of the Company which are set forth or incorporated in said
Part Three shall be for the benefit only of the holders of the bonds of the 3.20% Series due 2049, including the Additional Bonds
of the 3.20% Series. Such covenants and provisions shall remain in force and be applicable only so long as any bonds of the 3.20%
Series due 2049, including the Additional Bonds of the 3.20% Series, shall be outstanding, and, subject to the provisions of paragraph
(2) of subdivision (c) of §10.01 of the Indenture, any such covenants and provisions may be modified with respect to the bonds
of the 3.20% Series due 2049, including the Additional Bonds of the 3.20% Series, with the consent, in writing or by vote at a
bondholders’ meeting of the holders of sixty-six and two-thirds per cent (66 2/3 %) of the principal amount of the bonds
of the 3.20% Series due 2049 at the time outstanding, including the Additional Bonds of the 3.20% Series, and without the consent
of the holders of any other bonds then outstanding under the Indenture; provided that no such consent shall be effective
to waive any past default under such covenants and provisions, and its consequences, unless the consent of the holders of at least
a majority in principal amount of all bonds then outstanding under the Indenture is obtained. Such covenants shall be deemed to
be additional covenants and none of them shall affect or derogate from, or relieve the Company from, its obligation to comply with
any of the other covenants, conditions, requirements or provisions of the Indenture or any other supplemental indenture.

 

SECTION 2.       
All terms contained in this supplemental indenture shall, except as specifically provided herein or except as the context
may otherwise require, have the meanings given to such terms in the Indenture.

 

SECTION 3.       
In case any one or more of the provisions contained in this supplemental indenture should be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability shall not affect any other provision contained in this supplemental
indenture, and, to the extent, but only to the extent, that such provision is invalid, illegal or unenforceable, this supplemental
indenture shall be construed as if such provision had never been contained herein.

 

SECTION 4.       
The Trustee hereby accepts the trusts herein declared and provided upon the terms and conditions in the Indenture set
forth.

 

SECTION 5.       This
supplemental indenture may be executed in several counterparts, each of which shall be an original, and all collectively but one
instrument.

 

    5

     

    

 

SECTION 6.       
In addition to the amendment provisions of the Indenture, the terms and conditions of this supplemental indenture and
the Additional Bonds of the 3.20% Series may be modified, amended or supplemented by the Company and the Trustee, without the
consent of the holders of the bonds of the 3.20% Series due 2049, including the Additional Bonds of the 3.20% Series, and if not
inconsistent with the Indenture, to cure ambiguities in this supplemental indenture or the Additional Bonds of the 3.20% Series,
or correct defects or inconsistencies in the provisions of this supplemental indenture or the Additional Bonds of the 3.20% Series
or to provide for such appropriate additional provisions in this supplemental indenture or the Additional Bonds of the 3.20% Series
as are necessary for certificated bonds to be issued in lieu of Global Securities or to reflect additional provisions related
to the issuance of Global Securities (including changes in the procedures of the Depositary).

 

    6

     

    

 

 

IN WITNESS WHEREOF,
Duke Energy Carolinas, LLC, the party of the first part hereto, has caused this supplemental indenture to be signed in its name
by one of its Senior Vice Presidents and its company seal to be hereunto affixed, and the same to be attested by one of its Assistant
Secretaries, and The Bank of New York Mellon Trust Company, N.A., the party of the second part hereto, in token of its acceptance
of the trust hereby created, has caused this supplemental indenture to be signed in its name by one of its Vice Presidents and
its company seal to be hereunto affixed, and the same to be attested by one of its Vice Presidents, all as of the day and year
first above written.

 

	 	DUKE
    ENERGY CAROLINAS, LLC
	 	 
	 	By:  	/s/
    Karl W. Newlin
	 		Name:  	Karl W. Newlin
	 		Title:	Senior Vice President, Corporate
	 	 	 	Development and Treasurer

 

ATTEST:

 

	/s/ Robert T. Lucas III  	 
	Name:  	 Robert T. Lucas III	 
	Title:	 Assistant Secretary	 

 

Signed, sealed, executed, acknowledged

and delivered by Duke Energy

Carolinas, LLC, in the presence of:

 

	/s/ Carol Melendez	 
	Carol Melendez	 

 

	/s/ Aloma M. Felder	 
	Aloma M. Felder	 

 

[COMPANY’S SIGNATURE PAGE]

[ONE-HUNDRED AND FOURTH SUPPLEMENTAL INDENTURE

TO THE DUKE ENERGY CAROLINAS, LLC FIRST AND REFUNDING MORTGAGE

DATED AS OF DECEMBER 1, 1927]

 

     

     

    

 

	 	The Bank of New York Mellon Trust Company, N.A.,
	 	as Trustee
	 	 
	 	By:  	/s/ Mitchell L. Brumwell 
	 	 	Name:  	 Mitchell L. Brumwell
	 	 	Title:	Vice President

 

ATTEST:

 

	/s/ Robert W. Hardy	 
	Name:  	 Robert W. Hardy	 
	Title:	 Vice President	 

 

Signed, sealed, executed,

acknowledged and delivered by The Bank of New York

Mellon Trust Company, N.A.,

in the presence of:

 

	/s/ Lawrence M. Kusch	 
	Name:  	Lawrence M. Kusch	 

 

	/s/ Robert Castle	 
	Name:  	 Robert Castle	 

 

[TRUSTEE’S SIGNATURE PAGE]

[ONE-HUNDRED AND FOURTH SUPPLEMENTAL INDENTURE

TO THE DUKE ENERGY CAROLINAS, LLC FIRST AND REFUNDING MORTGAGE

DATED AS OF DECEMBER 1, 1927]

 

     

     

    

 

	State of Illinois	)
	 	) ss.:
	County of Cook	)

 

Personally appeared before me, Lawrence
M. Kusch, and made oath that he is not a party to or beneficiary of the transaction and that he saw Mitchell L. Brumwell, a Vice
President and Robert W. Hardy, a Vice President, respectively, of The Bank of New York Mellon Trust Company, N.A., sign, attest
and affix hereto the corporate seal of said The Bank of New York Mellon Trust Company, N.A., and, as the act and deed of said corporation,
deliver the within written and foregoing deed, and that he, with Robert Castle, witnessed the execution thereof.

 

	 	/s/
    Lawrence M. Kusch
	 	Name:  	Lawrence M. Kusch
	 	 
	 	Sworn
    and subscribed before me
	 	this
    6th day of January, 2020.
	 	 
	 	Mietka
    Collins
	 	Name:  	Mietka Collins
	 	Notary
    Public – State of Illinois
	 	Commission
    Expires 11/28/2022

 

	State of Illinois	)
	 	) ss.:
	County of Cook	)

 

I, Mietka Collins, a Notary Public in and
for the State aforesaid, certify that Robert W. Hardy personally came before me this day and acknowledged that he is a Vice President
of The Bank of New York Mellon Trust Company, N.A., a national banking association, and that, by authority duly given and as the
act of the corporation, the foregoing instrument was signed in its name by one of its Vice Presidents, sealed with its corporate
seal, and attested by himself as one of its Vice Presidents.

 

Witness may hand and official seal, this
6th day of January, 2020.

 

	 	/s/
    Mietka Collins
	 	Name:  	Mietka Collins
	 	Notary
    Public – State of Illinois
	 	Commission
    Expires 11/28/2022

 

     

     

    

 

	State of North Carolina	)
	 	) ss.:
	County of Mecklenburg	)

 

I, Phoebe P. Elliot, a Notary Public in
and for the State and County aforesaid, certify that Carol Melendez personally appeared before me this day, and being duly sworn,
stated that she is not a party to or beneficiary of the transaction and that in her presence Karl W. Newlin, Senior Vice President,
Corporate Development and Treasurer of Duke Energy Carolinas, LLC, executed the foregoing instrument, and that she, with Aloma
M. Felder, witnessed the execution thereof.

 

Witness my hand and official seal, this
8th day of January, 2020.

 

	 	/s/
    Carol Melendez
	 	Carol
    Melendez
	 	 
	 	/s/
    Phoebe P. Elliot
	 	Name:  	Phoebe P. Elliot
	 	Notary
    Public, State of North Carolina
	 	Mecklenburg
    County
	 	My
    Commission Expires: June 26, 2021

 

	State of North Carolina	)
	 	) ss.:
	County of Mecklenburg	)

 

I, Phoebe P. Elliot, a Notary Public in
and for the State and County aforesaid, certify that Robert T. Lucas III personally came before me this day and acknowledged that
he is an Assistant Secretary of Duke Energy Carolinas, LLC, a North Carolina limited liability company, and that, by authority
duly given and as the act of the company, the foregoing instrument was signed in its name by one of its Senior Vice Presidents,
sealed with its seal, and attested by himself as one of its Assistant Secretaries.

 

Witness my hand and official seal, this
8th day of January, 2020.

 

	 	/s/
    Phoebe P. Elliot
	 	Name:	 Phoebe P. Elliott
	 	Notary
    Public, State of North Carolina
	 	Mecklenburg
    County
	 	My
    Commission Expires: June 26, 2021Exhibit 10.1

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

THIS EXECUTIVE EMPLOYMENT
AGREEMENT (“Agreement”) is made and entered effective as of January 6, 2020, by and between Amplitude Healthcare
Acquisition Corporation (the “Company”) and Vishal Kapoor (the “Executive”).

 

W I T N E S S E T H:

 

WHEREAS, the
Board of Directors of the Company (the “Board”) has approved the Company entering into an employment agreement with
the Executive;

 

WHEREAS, the
Company has offered Executive the position of President of the Company;

 

WHEREAS, the
Company would like enter into a formal agreement with the Executive to set forth the terms of Executive’s employment;

 

NOW THEREFORE,
in consideration of the recitals and the mutual agreements herein set forth, the Company and the Executive agree as follows:

 

ARTICLE 1

EMPLOYMENT AND TERM

 

1.1 Employment. The
Company hereby employs Executive and Executive accepts employment as President of the Company. As its President, Executive shall
render such services to the Company as are customarily rendered by the President of comparable companies and as required by the
articles and by-laws of Company. Executive will also be responsible for leading and supporting the Company’s efforts to complete
a business combination with Amplitude, as described in the Company’s S-1. Executive accepts such employment and, consistent
with fiduciary standards which exist between and employer and an employee, shall perform and discharge the duties commensurate
with his position that may be assigned to him from time to time by the Company. Any and all prior employment agreements between
the Company and Executive are hereby terminated and are of no further force and effect.

 

1.2 Employment At-Will.
The term of Executive’s employment (“Term”) will not be for a definite period, but rather continue indefinitely
until terminated in accordance with the terms and conditions of this Agreement. Executive shall provide fifteen (15) days’
notice prior to resigning from his employment with the Company.

 

     

     

    

 

1.3 Compensation and Benefits.

 

a. Executive shall
be paid a base salary of $8,333.00 per month, less applicable withholdings.

 

b. Upon the successful
closing of a business combination with the Company, Executive shall be eligible to receive a one-time bonus in the amount of (a)
$550,000.00 (Five Hundred Fifty Thousand Dollars) if the underlying transaction is publicly announced on or before February 22,
2021, or (b) $300,000.00 (Three Hundred Thousand Dollars), if the underlying transaction is publicly announced after
February 22, 2021. The one-time bonus is contingent on Executive remaining continuously employed with the Company through the date
of the bonus payment. If Executive’s employment with the Company is terminated for reasons other than the reasons described
in Section 2.1 of this Agreement, Executive will still be eligible to receive the one-time bonus if the target of the business
combination was subject to a binding “letter of intent” or similar written agreement at the time of termination, subject
to the requirements in Section 2.3 of this Agreement.

 

c. Executive shall
be entitled to twenty (20) days of paid time off (PTO) for vacation, illness or personal business each full calendar year, beginning
January 1, 2020.

 

d. Executive shall
be eligible for fringe benefits offered by the Company. The Company may set the terms, amend or discontinue any benefit plan in
its sole discretion in accordance with applicable law.

 

1.4 Executive’s Agreement
with Amplitude Healthcare Holdings LLC. Executive will enter into a separate agreement with Amplitude Healthcare Holdings LLC
(“Sponsor”) which will provide Executive with a grant of a membership interest in the Sponsor, subject to the terms
and conditions contained therein.

 

ARTICLE 2

TERMINATION OF EMPLOYMENT AND SEVERANCE
BENEFITS

 

2.1 Termination by the Company
for Cause or Termination by the Executive without Good Reason, Death, or Disability. If the Executive’s employment is
terminated by the Company for Cause, or if his employment with the Company ends due to death, “permanent and total disability”
(within the meaning Section 22(e)(3) of Internal Revenue Code of 1986, as amended the “Code”), or due to a voluntary
termination of employment by the Executive without Good Reason, then the Executive shall only be entitled to any earned but unpaid
compensation as well as any other amounts or benefits owing to Executive under the terms of any employee benefit plan of the Company
(the “Accrued Benefits”).

 

    2 

     

    

 

2.2 Termination by the Company
without Cause or by the Executive for Good Reason. If the Executive’s employment with the Company is terminated by the
Company without Cause or is voluntarily terminated by the Executive for Good Reason, then the Executive shall be entitled to the
Severance Benefits as described in Section 2.3 herein as well as his Accrued Benefits.

 

2.3 Severance
Benefits.

 

a. In the event
that the Executive becomes entitled to receive severance benefits, as provided in Section 2.2 herein, the Company shall, unless
already remitted to Executive, pay to Executive the “one-time bonus” described in Section 1.3 of this Agreement provided
Executive has met the conditions precedent as described therein. Such severance shall be paid at the same time it would have been
paid had the Executive’s employment not been terminated.

 

b. As a condition
to receiving payments contemplated by this Article 2.3, within 30 days after the effective date of such termination Executive shall
execute and deliver, and not have revoked a general release in the form attached hereto as Exhibit “A”
(including, but not limited to, all matters relating to his employment with the Company) in favor of the Company and its affiliates
in such form as the Company shall reasonably request. The Severance Benefits shall terminate and be immediately returnable to Company
upon the Executive violating any of the provisions of Article III of this Agreement. Notwithstanding anything herein to the contrary,
in the event such 30-day period falls into two (2) calendar years, the payments contemplated in this Article 2.3 shall not commence
until the second calendar year and within the above-referenced 30-day period.

 

2.4 Good Reason. For purposes
of this Agreement, “Good Reason” shall mean the occurrence of any of the following, without the Executive’s prior
written consent: (i) a material diminution of Executive’s duties or responsibilities, (ii) a material reduction in Executive’s
Compensation or Benefits, (iii) a relocation of the Executive’s primary place of employment to a location more than sixty
(60) miles from the location at which the Executive was performing the Executive’s duties immediately prior to such relocation,
(iv) any requirement that the Executive report to anyone other than the Board and the Chief Executive Officer, or (v) any material
breach of this Agreement. However, none of the foregoing events or conditions will constitute Good Reason unless: (x) the Executive
provides the Company with written objection to the event or condition within 30 days following the occurrence thereof, (y) the
Company does not reverse or cure the event or condition within 30 days of receiving that written objection, and (z) the Executive
resigns his employment within 30 days following the expiration of that cure period.

 

    3 

     

    

 

2.5 Cause. For purposes of
this Agreement, “Cause” shall be deemed to exist upon any of the following events: (i) the Executive’s conviction
of, or plea of nolo contendere, to a felony, (ii) the Executive’s continued substance abuse or insobriety, (iii) failure
to substantially perform Executive’s essential job functions; (iv) failure of Executive to adhere to directives of the Board,
(v) Executive’s material misconduct or gross negligence, (vi) a material violation of any Company policy, or (v) any material
breach of this Agreement. The Board must provide 30 days’ written notice of its intent to terminate the Executive’s
employment for Cause. Prior to being terminated for Cause, the Executive shall have 30 days following the receipt of such written
notice to cure any curable event that would otherwise constitute Cause.

 

ARTICLE 3

RESTRICTIVE COVENANTS

 

3.1 Covenant not to Solicit.
Executive agrees that, for a period of one (1) year following his termination of employment with the Company, Executive will not
(i) directly or indirectly solicit for employment or employ any person who is or was employed by the Company within (6) six months
prior to his termination date, in any business in which the Executive has a material interest, direct or indirect, as an officer,
partner, shareholder or beneficial owner, or (ii) directly or indirectly solicit for employment or employ any person who is or
was employed by any business with which the Company engages in a business combination. Further, Executive will not assist any other
person or entity, in hiring or soliciting such employees, even if Executive does not have a material interest or is an officer,
partner, shareholder or owner. This Section 3.1 shall not prohibit Executive from soliciting or hiring any person who responds
to a general advertisement or solicitation that is not specifically directed at such employees.

 

3.2 Confidentiality and Nondisclosure.
The Executive will not use or disclose to any individual or entity any Confidential Information (as defined below) except (i) in
the performance of Executive’s duties for the Company, (ii) as authorized in writing by the Company, or (iii) as required by subpoena
or court order, provided that, prior written notice of such required disclosure is provided to the Company and, provided further
that all reasonable efforts to preserve the confidentiality of such information shall be made. As used in this Agreement, “Confidential
Information” shall mean information that (i) is used or potentially useful in the business of the Company, (ii) the Company
treats as proprietary, private or confidential, and (iii) is not generally known to the public. “Confidential Information”
includes, without limitation, information relating to the Company’s products or services, marketing, selling, customer lists, call
lists, customer data, memoranda, notes, records, plans, trade secrets, research and development data, sources of supply and material,
operating and cost data, financial information, personal information and information contained in manuals or memoranda. “Confidential
Information” also includes proprietary and/or confidential information of the Company’s customers, suppliers and trading
partners who may share such information with the Company pursuant to a confidentiality agreement or otherwise. The Executive agrees
to treat all such customer, supplier or trading partner information as “Confidential Information” hereunder. The foregoing
restrictions on the use or disclosure of Confidential Information shall continue after Executive’s employment terminates for any
reason for so long as the information is not generally known to the public. Nothing in this Agreement prohibits Executive from
disclosing a Company trade secret (i) in confidence to a Federal, State, or local government official, or to an attorney, solely
for the purpose of reporting or investigating a suspected violation of law or (ii) in a complaint or other document filed in a
lawsuit or other proceeding, if such filing is made under seal. Moreover, if Executive files a lawsuit for retaliation by an employer
for reporting a suspected violation of law, Executive may disclose a Company trade secret to the Executive’s attorney and
use the trade secret information in the court proceeding if Executive files any document containing the trade secret under seal
and does not disclose the trade secret except pursuant to court order.

 

    4 

     

    

 

3.3 Work Product and Copyrights.
Executive agrees that all right, title and interest in and to the materials resulting from the performance of Executive’s
duties at Company and all copies thereof, including works in progress, in whatever media, (“Work”), will be and remain
in Company upon their creation. Executive will mark all Work with Company’s copyright or other proprietary notice as directed
by Company. Executive further agrees:

 

a. To the extent
that any portion of the Work constitutes a work protectable under the copyright laws of the United States (the “Copyright
Law”), that all such Work will be considered a “work made for hire” as such term is used and defined in the Copyright
Law, and that Company will be considered the “author” of such portion of the Work and the sole and exclusive owner
throughout the world of copyright therein; and

 

b. If any portion
of the Work does not qualify as a “work made for hire” as such term is used and defined in the Copyright Law, that
Executive hereby assigns and agrees to assign to Company, without further consideration, all right, title and interest in and to
such Work or in any such portion thereof and any copyright therein and further agrees to execute and deliver to Company, upon request,
appropriate assignments of such Work and copyright therein and such other documents and instruments as Company may request to fully
and completely assign such Work and copyright therein to Company, its successors or nominees, and that Executive hereby appoints
Company as attorney-in-fact to execute and deliver any such documents on Executive’s behalf in the event Executive should
fail or refuse to do so within a reasonable period following Company’s request.

 

    5 

     

    

 

3.4 Non-Disparagement. The
Executive will not at any time during his employment with the Company, or after the termination of his employment with the Company,
directly or indirectly (i) disparage, libel, defame, ridicule or make negative comments regarding, or encourage or induce others
to disparage, libel, defame, ridicule or make negative comments regarding, the Company, or any of the Company’s officers, directors,
employees or agents, or the Company’s products, services, business plans or methods; or (ii) engage in any conduct or encourage
or induce any other person to engage in any conduct that is in any way injurious or potentially injurious to the reputation or
interests of the Company or any of the Company’s, officers, directors, employees or agents.

 

3.5 Covenant not to Compete.
Executive agrees not to become an employee, officer, director, or consultant of any other blank check company with a class of securities
registered under the Securities Exchange Act of 1934, as amended, unless the Company has failed to complete a business combination
within 24 months after the closing of the Public Offering. Such restriction does not preclude any position as an officer or director
of another blank check company held on the date hereof. For the avoidance of doubt, Executive is allowed to become an employee,
officer or director of another blank check company upon the Company entering into a definitive agreement with respect to a business
combination. Executive further agrees for a period of six (6) months following Executive’s termination of employment with
the Company not to become an employee, officer, director, or consultant of any business seeking to acquire or merge with a business
that was subject to a binding “letter of intent” or similar written agreement at the time of termination. Executive
further agrees that he will not, without the prior express written consent of the Company (i) use for the benefit Executive or
a third party, (ii) use for the detriment of the Company, or (iii) disclose to any third party (unless required by law or governmental
authority), any information regarding a potential business acquisition target of the Company that is not generally known by persons
outside of the Company, the Sponsor, or their respective affiliates.

 

3.6 Restrictions Reasonable.
Executive acknowledges that the restrictions under this Article III are substantial, and may effectively prohibit him from working
for a period of one year in the field of his experience and expertise. Executive further acknowledges that he has been given access
and shall continue to be given access to all of the Confidential Matters and trade secrets described above during the course of
his employment, and therefore, the restrictions are reasonable and necessary to protect the competitive business interests and
goodwill of the Company and do not cause Executive undue hardship.

 

3.7 Survival of Restrictive Covenants.
Executive’s obligations under this Agreement shall survive Executive’s termination of employment with the Company and the
termination of this Agreement.

 

    6 

     

    

 

3.8 Equitable Relief. Executive
hereby acknowledges and agrees that the Company and its goodwill would be irreparably injured by, and that damages at law are an
insufficient remedy for, a breach or violation of the provisions of this Agreement, and agrees that the Company, in addition to
other remedies available to it for such breach shall be entitled to a preliminary injunction, temporary restraining order, or other
equivalent relief, restraining Executive from any actual breach of the provisions hereof, and that the Company’s rights to
such equitable relief shall be cumulative and in addition to any other rights or remedies to which the Company may be entitled.

 

3.9 Return of Company Property.
Upon termination of employment or upon request of the Company, Executive shall deliver to the Company all property, documents and
materials pertaining to the Company’s business including, but not limited to, memoranda, notes, records, drawings, manuals,
disks, copies, representations, extracts, summaries and analyses, and any other property, documents or media of the Company, and
all equipment belonging to the Company, including but not limited to corporate cards, access cards, office keys, office equipment,
laptop and desktop computers, cell phones and other wireless devices, thumb drives, zip drives and all other media storage devices.

 

3.10 Future Cooperation. The
parties agree that certain matters in which Executive will be involved during his employment may necessitate Executive’s cooperation
in the future. Accordingly, following the termination of Executive’s employment for any reason, to the extent reasonably requested
by the Company, Executive shall cooperate with the Company in connection with matters arising out of Executive’s service to the
Company; provided that, the Company shall make reasonable efforts to minimize disruption of Executive’s other activities. The Company
shall reimburse Executive for reasonable expenses incurred in connection with such cooperation.

 

ARTICLE 4

MISCELLANEOUS

 

4.1 Entire Agreement. This
Agreement contains the entire understanding of the Company and the Executive with respect to the subject matter hereof.

 

4.2 Prior Agreement. This Agreement
supersedes and replaces any prior oral or written employment or severance agreement between the Executive and the Company.

 

4.3 Subsidiaries. Where appropriate
in this Agreement, the term “Company” shall also include any direct or indirect subsidiaries of the Company.

 

    7 

     

    

 

4.4 Compliance with Code Section
409A.

 

a. It is the intention
of both the Company and Executive that the benefits and rights to which Executive could be entitled pursuant to this Agreement
comply with Section 409A of the Internal Revenue Code, and its implementing regulations and guidance (“Section 409A”),
to the extent that the requirements of Section 409A are applicable thereto, and the provisions of this Agreement shall be construed
in a manner consistent with that intention.

 

b. If and to the
extent required to comply with any payment or benefit required to be paid under this Agreement on account of termination of Executive’s
employment, service (or any other similar term) shall be made only in connection with a “separation from service” with
respect to Executive within the meaning of Section 409A.

 

c. In the event
that the Executive is a “specified employee” (as described in Section 409A), and any payment or benefit payable pursuant
to this Agreement constitutes deferred compensation subject to the six-month delay requirement described in Section 409A(2)(b),
then no such payment or benefit shall be made before six months after the Executive’s “separation from service”
(as described in Section 409A) (or, if earlier, the date of the Executive’s death). Any payment or benefit delayed by reason
of the prior sentence shall be paid out or provided in a single lump sum at the end of such required delay period in order to catch
up to the original payment schedule.

 

d. For purposes
of applying the provisions of Section 409A to this Agreement, each separately identified amount to which the Executive is entitled
under this Agreement shall be treated as a separate payment. In addition, to the extent permissible under Section 409A, any series
of installment payments under this Agreement shall be treated as a right to a series of separate payments.

 

4.5 Severability. It is mutually
agreed and understood by the parties that should any of the restrictions and covenants contained in Article III be determined by
any court of competent jurisdiction to be invalid by virtue of being vague, overly broad, unreasonable as to time, territory or
otherwise, then the Agreement shall be amended retroactive to the date of its execution to include the terms and conditions which
such court deems to be reasonable and in conformity with the original intent of the parties and the parties hereto consent that
under such circumstances, such court shall have the power and authority to determine what is reasonable and in conformity with
the original intent of the parties to the extent that such restrictions and covenants are enforceable. In the event any other provision
of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining
parts of the Agreement, and the Agreement shall be construed and enforced as if the illegal or invalid provision had not been included.

 

    8 

     

    

 

4.6 Modification. No provision
of this Agreement may be modified, waived, or discharged unless such modification, waiver, or discharge is agreed to in writing
and signed by the Executive and by an authorized officer of the Company on the Company’s behalf, or by the respective parties’
legal representations and successors.

 

4.7 Dispute Resolution. All
disputes regarding this agreement and/or Executive’s employment with the Company shall resolved by arbitration to be administered
by the American Association of Arbitration in New York, New York in accordance with the AAA’s “Employment Arbitration
Rules and Mediation Procedures.” Unless otherwise agreed, the prevailing party will be entitled to its costs and reasonable
attorneys’ fees incurred in any litigation or dispute relating to the interpretation or enforcement of this Agreement. Judgment
on the award may be entered in any court having jurisdiction. This clause shall not preclude parties from seeking provisional remedies
in aid of arbitration from a court of appropriate jurisdiction. There is no right or authority for any claims subject to this arbitration
policy to be arbitrated on a class or collective action basis or on any basis involving claims brought in a purported representative
capacity on behalf of any other person or group of people similarly situated. Such claims are prohibited. Furthermore, claims brought
by or against either the Executive or Company may not be joined or consolidated in the arbitration with claims brought by or against
any other person or entity unless otherwise agreed to in writing by all parties involved.

 

4.8 Governing Law. To the extent
not preempted by the laws of the United States, the terms and provisions of this agreement are governed by and shall be interpreted
in accordance with, the laws of the state of New York, without giving effect to any choice of law principles, except that the “Dispute
Resolution” provision above shall be governed solely by the Federal Arbitration Act.

 

4.9 Legal Fees and Expenses.
The prevailing party any arbitration to enforce the terms of this Agreement shall be entitled to recover reasonable costs and expenses,
including attorneys’ fees.

 

4.10 Costs and Fees Related to
Negotiation and Execution of Agreement. Each party shall be responsible for the payment of its own costs and expenses, including
legal fees and expenses, in connection with the negotiation and execution of this Agreement.

 

4.11 Successors and Assigns.
This Agreement shall inure to the benefit of and be enforceable by the Company’s successors and/or assigns. This Agreement shall
not be assignable by Executive.

 

    9 

     

    

 

4.12 Headings/References. The
headings in this Agreement are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect
the meaning thereof.

 

4.13 Notices. Any notice, request,
instruction, or other document to be given hereunder shall be in writing and shall be deemed to have been given: (a) on the day
of receipt, if sent by overnight courier; (b) upon receipt, if given in person; (c) five days after being deposited in the mail,
certified or registered mail, postage prepaid, and in any case addressed as follows:

 

If to the Company: 

1177 Avenue of the Americas,
Floor 40

New York,
NY 10036 

Attn: Chairperson,
Board of Directors

 

With a copy
that shall not constitute notice to:

 

Stuart Neuhauser,
Esq.

Ellenoff
Grossman & Schole LLP

1345 Avenue
of the Americas, 11th Floor

New York,
New York 10105

 

If to the Executive: 

10 Strong Place, Apt. 1

Brooklyn,
NY 11231

 

or to such other address or to the attention
of such other person as the recipient party has specified by prior written notice to the sending party.

 

4.14 Representation of Executive.
Executive represents and warrants to Company that Executive is free to enter into this Agreement and has no contract, commitment,
arrangement or understanding to or with any party that restrains or is in conflict with Executive’s performance of the covenants,
services and duties provided for in this Agreement, and does not contravene the terms of any statute, law, or regulation to which
Executive is subject. Executive agrees to indemnify Company and to hold it harmless against any and all liabilities or claims arising
out of any unauthorized act or acts by Executive that, the foregoing representation and warranty to the contrary notwithstanding,
are in violation, or constitute a breach, of any such contract, commitment, arrangement or understanding.

 

    10 

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Agreement on this 6th day of January 2020.

 

	 	AMPLITUDE HEALTHCARE
	 	ACQUISITION CORPORATION
	 	 
	 	By: 	/s/
    Bala Venkataraman
	 	Name: 	Bala Venkataraman
	 	Title: 	Chief Executive Officer
	 	 
	 	/s/ Vishal Kapoor
	 	Vishal Kapoor

 

    11 

     

    

 

EXHIBIT A

FORM OF RELEASE

GENERAL RELEASE OF CLAIMS

 

1. ________________
(“Executive”), for himself and his family, heirs, executors, administrators, legal representatives and their
respective successors and assigns, in exchange for the Severance Benefits, as defined under the Executive Employment Agreement
made and entered effective as of the ___ day of ______________, by and between Amplitude Healthcare Acquisition Corporation [or
its successor], (the “Company”) and ____________ (the “Executive”), to which this release is attached as
Exhibit A (the “Employment Agreement”), does hereby release and forever discharge the Company, its subsidiaries,
affiliated companies, successors and assigns, and its current or former directors, officers or shareholders in such capacities
(collectively with the Company, the “Released Parties”) from any and all actions, causes of action, suits, controversies,
claims and demands whatsoever, for or by reason of any matter, cause or thing whatsoever, whether known or unknown including, but
not limited to, all claims under any applicable laws arising under or in connection with Executive’s employment or termination
thereof, whether for tort, breach of express or implied employment contract, wrongful discharge, intentional infliction of emotional
distress, or defamation or injuries incurred on the job or incurred as a result of loss of employment, including but not limited
to any claims arising under Section 120 of New York Worker’s Compensation law; the National Labor Relations Act, 29 U.S.C. §151
et seq.; the Fair Labor Standards Act, 29 U.S.C. §201, et seq.; the Employee Retirement Income Security Act of 1974, 29 U.S.C.
§1001 et seq.; the Civil Rights Acts of 1964 and 1991, 42 U.S.C. §2000e et seq.; the Civil Rights Act of 1866, 42 U.S.C.
§1981 et seq.; the Rehabilitation Act of 1973, 29 U.S.C. §701 et seq.; the Equal Pay Act of 1963, 29 U.S.C. §206(d);
the Americans with Disabilities Act, 42 U.S.C. §12101 et seq.; the Age Discrimination in Employment Act, 29 U.S.C. §621
et seq.; the Consolidated Omnibus Budget Reconciliation Act of 1985, I.R.C. § 4980B; the Genetic Information Nondiscrimination
Act, 42 U.S.C. § 2000ff; the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1514A, et seq., the Dodd-Frank Wall Street Reform
and Consumer Protection Act, Pub Law. No. 111-203; the New York State Human Rights Law, New York Executive Law § 290 et seq.;
the New York City Human Rights Law, Title 8, Chapter 1 of the Administrative Code of the City of New York; the New York State Civil
Rights Law, Civil Rights Law § 40 et seq.; the New York Equal Pay Law, Labor Law §§ 194-198; the New York Whistleblower
Law, Labor Law § 740; the New York Workers’ Compensation Law, Workers’ Compensation Law § 1 et seq.; the
New York City Earned Safe and Sick Time Act; the New York Paid Family Leave Benefit Law; the New York occupational safety and health
laws; the New York wage hour and wage-payment laws; and/or any other federal, state or local statute, law, ordinance, regulation
or order, or the common law, or any self-regulatory organization rule or regulation (“Release”).

 

    12 

     

    

 

Executive acknowledges
that the Company encouraged him to consult with an attorney of his choosing prior to executing this General Release. Notwithstanding
anything in this paragraph 1 to the contrary, this General Release of Claims shall not apply to (i) any rights to receive any payments
or benefits to which Executive is entitled under COBRA, the Employment agreement or any other compensation or employee benefit
plans in which Executive is eligible to participate at the time of execution of this General Release of Claims, (ii) any rights
or claims that may arise as a result of events occurring after the date this General Release of Claims is executed, (iii) any indemnification
and advancement rights Executive may have as a former employee, officer or director of the Company or its subsidiaries or affiliated
companies including, without limitation, any rights arising pursuant to the articles of incorporation, bylaws and any other organizational
documents of the Company or any of its subsidiaries, (iv) any claims for benefits under any directors’ and officers’
liability policy maintained by the Company or its subsidiaries or affiliated companies in accordance with the terms of such policy,
and (v) any rights as a holder of equity securities of the Company (clauses (i) through (v), the “Reserved Claims”).

 

2. Executive represents
that he has not filed against the Released Parties any complaints, charges, or lawsuits arising out of his employment, or any other
matter arising on or prior to the date of this General Release of Claims other than Reserved Claims, and covenants and agrees that
he will never individually or with any person file, or commence the filing of any lawsuits, complaints or proceedings with any
governmental agency, or against the Released Parties with respect to any of the matters released by Executive pursuant to paragraph
1 hereof (a “Proceeding”); provided, however, Executive shall not have relinquished his right
to (i) file a charge with an administrative agency or take part in any agency investigation or (ii) commence a Proceeding pursuant
to the Reserved Claims. Executive does agree, however, that he is waiving his right to recover any money in connection with such
an investigation or charge filed by him or by any other individual, or a charge filed by the Equal Employment Opportunity Commission
or any other federal, state or local agency, except as prohibited by law.

 

3. Executive hereby
acknowledges that the Company has informed him that he has up to twenty-one (21) days to sign this General Release of Claims and
he may knowingly and voluntarily waive that twenty-one (21) day period by signing this General Release of Claims earlier. Executive
also understands that he shall have seven (7) days following the date on which he signs this General Release of Claims within which
to revoke it by providing a written notice of his revocation to the Company.

 

4. Executive acknowledges
that this General Release of Claims will be governed by and construed and enforced in accordance with the internal laws of the
laws of New York, without giving effect to any choice of law principles.

 

    13 

     

    

 

5. Executive acknowledges
that he has read this General Release of Claims, that he has been advised that he should consult with an attorney before he executes
this general release of claims, and that he understands all of its terms and executes it voluntarily and with full knowledge of
its significance and the consequences thereof.

 

6. This General
Release of Claims shall take effect on the eighth day following Executive’s execution of this General Release of Claims unless
Executive’s written revocation is delivered to the Company within seven (7) days after such execution.

 

	 	EXECUTIVE
	 	 
	 	/s/
    Vishal Kapoor
	 	Vishal Kapoor

 

 

14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]